Great Lakes Advisors LLC Invests $788,000 in Guardian Pharmacy Services, Inc. $GRDN

Great Lakes Advisors LLC acquired a new stake in Guardian Pharmacy Services, Inc. (NYSE:GRDN) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund acquired 18,810 shares of the company’s stock, valued at approximately $788,000.

A number of other institutional investors also recently modified their holdings of the stock. Dynamic Technology Lab Private Ltd bought a new position in Guardian Pharmacy Services during the first quarter worth $233,000. JPMorgan Chase & Co. raised its holdings in shares of Guardian Pharmacy Services by 48.0% during the second quarter. JPMorgan Chase & Co. now owns 6,027 shares of the company’s stock valued at $128,000 after purchasing an additional 1,956 shares during the period. Legal & General Group Plc raised its holdings in shares of Guardian Pharmacy Services by 1,783.1% during the second quarter. Legal & General Group Plc now owns 14,895 shares of the company’s stock valued at $317,000 after purchasing an additional 14,104 shares during the period. Rhumbline Advisers boosted its position in shares of Guardian Pharmacy Services by 121.1% during the 2nd quarter. Rhumbline Advisers now owns 16,174 shares of the company’s stock worth $345,000 after purchasing an additional 8,860 shares in the last quarter. Finally, Quantbot Technologies LP bought a new position in shares of Guardian Pharmacy Services during the 2nd quarter worth about $214,000.

Guardian Pharmacy Services Price Performance

GRDN opened at $37.90 on Friday. Guardian Pharmacy Services, Inc. has a 1 year low of $23.14 and a 1 year high of $47.02. The company has a market capitalization of $1.89 billion, a price-to-earnings ratio of 36.80, a P/E/G ratio of 1.96 and a beta of 0.10. The firm’s fifty day moving average price is $40.44 and its two-hundred day moving average price is $37.71.

Guardian Pharmacy Services (NYSE:GRDN) last announced its earnings results on Thursday, August 6th. The company reported $0.29 EPS for the quarter, beating the consensus estimate of $0.26 by $0.03. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%. The company had revenue of $351.77 million during the quarter, compared to the consensus estimate of $340.45 million. As a group, equities analysts anticipate that Guardian Pharmacy Services, Inc. will post 1.19 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on GRDN shares. Wall Street Zen raised Guardian Pharmacy Services from a “hold” rating to a “buy” rating in a research report on Sunday, August 9th. Bank of America increased their price target on Guardian Pharmacy Services from $42.00 to $47.00 and gave the stock a “buy” rating in a report on Wednesday, June 17th. Oppenheimer raised their price objective on Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an “outperform” rating in a research note on Friday, August 7th. Truist Financial boosted their price objective on Guardian Pharmacy Services from $43.00 to $47.00 and gave the company a “buy” rating in a report on Wednesday, June 17th. Finally, Zacks Research lowered Guardian Pharmacy Services from a “strong-buy” rating to a “hold” rating in a research report on Monday, May 11th. Eight analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, Guardian Pharmacy Services currently has a consensus rating of “Moderate Buy” and a consensus target price of $43.83.

Guardian Pharmacy Services Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.